Trenton, May 18, 2026 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning today’s full General Assembly passage of A-1502, the “Patient and Provider Protection Act.” 

“We applaud the Assembly’s passage of this important legislation, which will improve access to life-saving medications and lower costs for patients.  New Jersey is known as the ‘Medicine Chest of the World’ for our global leadership in discovering new medicines – this bill aims to make sure PBMs and other middlemen don’t artificially inflate the cost of those medicines for their own profits at the expense of New Jersey patients.”

Buteas continued, “Today’s action by the Assembly addresses the critical goal of making healthcare more affordable, helping patients and families across our state.  We look forward to supporting the bill as it continues through the legislative process.”

# # #

About the HealthCare Institute of New Jersey (HINJ)

Founded in 1997, the HealthCare Institute of New Jersey (HINJ) is a trade association that serves as the voice for our state’s leading research-based biopharmaceutical and medical technology companies. HINJ strives to raise awareness, understanding and public support for the state’s life sciences industry, expand patient access to the medical innovations our member companies produce and promote awareness of the life sciences’ economic impact in New Jersey.

To learn more, please visit www.hinj.org and follow us on X, Facebook and LinkedIn. For data on the life sciences’ impact on New Jersey’s economy, visit our By the Numbers page.